160 related articles for article (PubMed ID: 34075706)
21. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.
Vissers LELM; van Nimwegen KJM; Schieving JH; Kamsteeg EJ; Kleefstra T; Yntema HG; Pfundt R; van der Wilt GJ; Krabbenborg L; Brunner HG; van der Burg S; Grutters J; Veltman JA; Willemsen MAAP
Genet Med; 2017 Sep; 19(9):1055-1063. PubMed ID: 28333917
[TBL] [Abstract][Full Text] [Related]
22. The utility of whole exome sequencing in diagnosing neurological disorders in adults from a highly consanguineous population.
Mu W; Schiess N; Orthmann-Murphy JL; El-Hattab AW
J Neurogenet; 2019 Mar; 33(1):21-26. PubMed ID: 30724636
[TBL] [Abstract][Full Text] [Related]
23. Genetics: Clinical exome sequencing in neurology practice.
Miyatake S; Matsumoto N
Nat Rev Neurol; 2014 Dec; 10(12):676-8. PubMed ID: 25366112
[TBL] [Abstract][Full Text] [Related]
24. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic pathway in complex paediatric neurology: a cost analysis.
van Nimwegen KJ; Schieving JH; Willemsen MA; Veltman JA; van der Burg S; van der Wilt GJ; Grutters JP
Eur J Paediatr Neurol; 2015 Mar; 19(2):233-9. PubMed ID: 25604808
[TBL] [Abstract][Full Text] [Related]
26. Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.
Harris E; Topf A; Barresi R; Hudson J; Powell H; Tellez J; Hicks D; Porter A; Bertoli M; Evangelista T; Marini-Betollo C; Magnússon Ó; Lek M; MacArthur D; Bushby K; Lochmüller H; Straub V
Orphanet J Rare Dis; 2017 Sep; 12(1):151. PubMed ID: 28877744
[TBL] [Abstract][Full Text] [Related]
27. A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders.
Ngo KJ; Rexach JE; Lee H; Petty LE; Perlman S; Valera JM; Deignan JL; Mao Y; Aker M; Posey JE; Jhangiani SN; Coban-Akdemir ZH; Boerwinkle E; Muzny D; Nelson AB; Hassin-Baer S; Poke G; Neas K; Geschwind MD; Grody WW; Gibbs R; Geschwind DH; Lupski JR; Below JE; Nelson SF; Fogel BL
Hum Mutat; 2020 Feb; 41(2):487-501. PubMed ID: 31692161
[TBL] [Abstract][Full Text] [Related]
28. The combination of whole-exome sequencing and copy number variation sequencing enables the diagnosis of rare neurological disorders.
Jiao Q; Sun H; Zhang H; Wang R; Li S; Sun D; Yang XA; Jin Y
Clin Genet; 2019 Aug; 96(2):140-150. PubMed ID: 30945278
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
Monroe GR; Frederix GW; Savelberg SM; de Vries TI; Duran KJ; van der Smagt JJ; Terhal PA; van Hasselt PM; Kroes HY; Verhoeven-Duif NM; Nijman IJ; Carbo EC; van Gassen KL; Knoers NV; Hövels AM; van Haelst MM; Visser G; van Haaften G
Genet Med; 2016 Sep; 18(9):949-56. PubMed ID: 26845106
[TBL] [Abstract][Full Text] [Related]
30. Informing a value care model: lessons from an integrated adult neurogenomics clinic.
McLean A; Tchan M; Devery S; Smyth R; Shrestha R; Kumar KR; Tomlinson S; Tisch S; Wu KHC
Intern Med J; 2023 Dec; 53(12):2198-2207. PubMed ID: 37092903
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel.
Tal-Ben Ishay R; Shil A; Solomon S; Sadigurschi N; Abu-Kaf H; Meiri G; Flusser H; Michaelovski A; Dinstein I; Golan H; Davidovitch N; Menashe I
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052376
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients.
Tsang MHY; Chiu ATG; Kwong BMH; Liang R; Yu MHC; Yeung KS; Ho WHL; Mak CCY; Leung GKC; Pei SLC; Fung JLF; Wong VCN; Muntoni F; Chung BHY; Chan SHS
Mol Genet Genomic Med; 2020 May; 8(5):e1205. PubMed ID: 32154989
[TBL] [Abstract][Full Text] [Related]
33. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
[TBL] [Abstract][Full Text] [Related]
34. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned.
Ghaoui R; Cooper ST; Lek M; Jones K; Corbett A; Reddel SW; Needham M; Liang C; Waddell LB; Nicholson G; O'Grady G; Kaur S; Ong R; Davis M; Sue CM; Laing NG; North KN; MacArthur DG; Clarke NF
JAMA Neurol; 2015 Dec; 72(12):1424-32. PubMed ID: 26436962
[TBL] [Abstract][Full Text] [Related]
35. Molecular findings among patients referred for clinical whole-exome sequencing.
Yang Y; Muzny DM; Xia F; Niu Z; Person R; Ding Y; Ward P; Braxton A; Wang M; Buhay C; Veeraraghavan N; Hawes A; Chiang T; Leduc M; Beuten J; Zhang J; He W; Scull J; Willis A; Landsverk M; Craigen WJ; Bekheirnia MR; Stray-Pedersen A; Liu P; Wen S; Alcaraz W; Cui H; Walkiewicz M; Reid J; Bainbridge M; Patel A; Boerwinkle E; Beaudet AL; Lupski JR; Plon SE; Gibbs RA; Eng CM
JAMA; 2014 Nov; 312(18):1870-9. PubMed ID: 25326635
[TBL] [Abstract][Full Text] [Related]
36. The Results of Whole Exome Sequencing Performed On Previously Undiagnosed Pediatric Neurology Patients.
Ahmadnia N; Beiraghi Toosi M; Ghayour Karimiani E; Ashrafzadeh F; Faraji Rad M
Iran J Child Neurol; 2021; 15(2):17-31. PubMed ID: 36213152
[TBL] [Abstract][Full Text] [Related]
37. Ordering genetic testing by neurologists: points to consider.
Fellner A; Goldberg Y; Basel-Salmon L
J Neurol; 2023 Aug; 270(8):3714-3722. PubMed ID: 37154893
[TBL] [Abstract][Full Text] [Related]
38. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.
Stark Z; Schofield D; Martyn M; Rynehart L; Shrestha R; Alam K; Lunke S; Tan TY; Gaff CL; White SM
Genet Med; 2019 Jan; 21(1):173-180. PubMed ID: 29765138
[TBL] [Abstract][Full Text] [Related]
39. Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service.
Westra D; Schouten MI; Stunnenberg BC; Kusters B; Saris CGJ; Erasmus CE; van Engelen BG; Bulk S; Verschuuren-Bemelmans CC; Gerkes EH; de Geus C; van der Zwaag PA; Chan S; Chung B; Barge-Schaapveld DQCM; Kriek M; Sznajer Y; van Spaendonck-Zwarts K; van der Kooi AJ; Krause A; Schönewolf-Greulich B; de Die-Smulders C; Sallevelt SCEH; Krapels IPC; Rasmussen M; Maystadt I; Kievit AJA; Witting N; Pennings M; Meijer R; Gillissen C; Kamsteeg EJ; Voermans NC
J Neuromuscul Dis; 2019; 6(2):241-258. PubMed ID: 31127727
[TBL] [Abstract][Full Text] [Related]
40. Limitations of exome sequencing in detecting rare and undiagnosed diseases.
Burdick KJ; Cogan JD; Rives LC; Robertson AK; Koziura ME; Brokamp E; Duncan L; Hannig V; Pfotenhauer J; Vanzo R; Paul MS; Bican A; Morgan T; Duis J; Newman JH; Hamid R; Phillips JA;
Am J Med Genet A; 2020 Jun; 182(6):1400-1406. PubMed ID: 32190976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
